Nagorsen, Dirk Priv.-Doz. Dr. med.Universität HeidelbergHeidelberg
Publikationsliste einschränken
Publikationsjahre
Publikationstypen
Sprache
Co-Autoren (extern)
Publikationen in heiBIB 
- Papadopoulos, Kyriakos P.: First-in-human study of AMG 820, a monoclonal anti-colony-stimulating factor 1 receptor antibody, in patients with advanced solid tumors / Kyriakos P. Papadopoulos, Larry Gluck, Lainie P. Martin, Anthony J. Olszanski, Anthony W. Tolcher, G… , October 2017. - 8 S.
In: Clinical cancer research, ISSN 1557-3265. 23(2017), 19, Seite 5703-5710
DOI: 10.1158/1078-0432.CCR-16-3261
- Kantarjian, Hagop: Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia / Hagop Kantarjian, M.D., Anthony Stein, M.D., Nicola Gökbuget, M.D., Adele K. Fielding, M.B., B.S., P… , March 2, 2017. - 12 S.
In: The New England journal of medicine, ISSN 1533-4406. 376(2017), 9, Seite 836-847
DOI: 10.1056/NEJMoa1609783
- Goebeler, Maria-Elisabeth: Bispecific T-cell engager (BiTE) antibody construct blinatumomab for the treatment of patients with relapsed/refractory non-hodgkin lymphoma : final results from a phase I study / Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot, Peter Kufer, Max S. Topp, Hermann Einsele, R… , April 1, 2016. - 13 S.
In: Journal of clinical oncology, ISSN 1527-7755. 34(2016), 10, Seite 1104-1111
DOI: 10.1200/JCO.2014.59.1586
- Viardot, Andreas: Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma / Andreas Viardot, Marie-Elisabeth Goebeler, Georg Hess, Svenja Neumann, Michael Pfreundschuh, Nicole … , January 11, 2016. - 7 S.
In: Blood, ISSN 1528-0020. 127(2016), 11, Seite 1410-1416
DOI: 10.1182/blood-2015-06-651380
- Aldoss, Ibrahim: Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia : bispecific T-cell engagers and chimeric antigen receptors / I. Aldoss, R.C. Bargou, D. Nagorsen, G.R. Friberg, P.A. Baeuerle and S.J. Forman, 2017. - 11 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 4, Seite 777-787
DOI: 10.1038/leu.2016.391
- Stieglmaier, Julia: Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer / Julia Stieglmaier, Jonathan Benjamin and Dirk Nagorsen, 13 May 2015. - 7 S.
In: Expert opinion on biological therapy, ISSN 1744-7682. 15(2015), 8, Seite 1093-1099
DOI: 10.1517/14712598.2015.1041373
- Zimmerman, Zachary: Unleashing the clinical power of T cells : CD19/CD3 bi-specific T cell engager (BiTE) antibody construct blinatumomab as a potential therapy / Zachary Zimmerman, Tapan Maniar and Dirk Nagorsen, January 2015. - 7 S.
In: International immunology, ISSN 1460-2377. 27(2015), 1, Seite 31-37
DOI: 10.1093/intimm/dxu089
- Topp, Max S.: Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia : a multicentre, single-arm, phase 2 study / Max S. Topp, Nicola Gökbuget, Anthony S. Stein, Gerhard Zugmaier, Susan O'Brien, Ralf C. Bargou, Her… , January 2015. - 10 S.
In: The lancet, ISSN 1474-5488. 16(2015), 1, Seite 57-66
DOI: 10.1016/S1470-2045(14)71170-2
- Golay, Josée: A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy / Josée Golay, Anna D'Amico, Gianmaria Borleri, Michela Bonzi, Rut Valgardsdottir, Rachele Alzani, Sab… , 29. September 2014. - 9 S.
In: The journal of immunology, ISSN 1550-6606. 193(2014), 9, Seite 4739-4747
DOI: 10.4049/jimmunol.1401550
- Wong, Ryan: Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells / Wong, Ryan ... Nagorsen, Dirk ..., 2013. - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 98(2013), 12, Seite 1930-1938
DOI: 10.3324/haematol.2012.082248
IDs
Links
Nagorsen, Dirk in ...
Export Publikationsliste
heiBIB
Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.
Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).
